SOBRsafe Inc. Secures European Patent for Innovative Alcohol Detection Technology
SOBRsafe Inc. has been granted a European patent for its SOBRcheck device, marking a significant advancement in noninvasive alcohol monitoring technology with implications for workplace safety and judicial compliance.
SOBRsafe Inc. (NASDAQ: SOBR), a pioneer in next-generation alcohol monitoring solutions, has achieved a milestone with the European Patent Office granting European Patent No. EP4171362 for its SOBRcheck(TM) device. This patent underscores the company's innovative approach to alcohol detection, utilizing a noninvasive transdermal system that combines skin-contact verification, biometric ID scanning, and wireless data transmission to identify alcohol consumption without the need for breath, blood, or urine samples.
The significance of this patent extends beyond technological achievement; it solidifies SOBRsafe's foothold in critical markets such as workplace safety, judicial compliance, and wellness. With planned European pilot programs set for the second half of 2025, the company is poised to introduce its groundbreaking technology to a broader audience, offering a passive and dignified solution for alcohol screening and monitoring.
For more details on SOBRsafe's innovative technology and its potential impact, visit https://ibn.fm/kSwer. Additional information about SOBRsafe and its mission to enable trust and empower recovery through advanced alcohol detection can be found at https://www.sobrsafe.com.
Investors and stakeholders interested in the latest developments regarding SOBRsafe can access updates in the company's newsroom at https://ibn.fm/SOBR. This patent not only represents a leap forward in alcohol detection technology but also highlights SOBRsafe's commitment to providing solutions that address the needs of the behavioral health, family law, and consumer markets, as well as opportunities for licensing and integration.